What is Mosquirix, the world's first malaria vaccine to get WHO's approval?
What is Mosquirix, the world’s first malaria vaccine to get WHO’s approval?
Mosquirix (RTS,S), recommended by WHO for widespread use, is the first vaccine that is around 30% effective against severe cases of the mosquito-borne disease malaria and is given to children aged 6 weeks to 17 months. GlaxoSmithKline’s four-dose vaccine, which was under development for 30 years, acts against Plasmodium falciparum, the deadliest malaria parasite, which is most prevalent in Africa.
View On WordPress












